LENZ Therapeutics, Inc (LENZ) insider trading
Every open-market stock purchase and sale by LENZ Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $655K over the last 12 months (5 buys).
- Insiders sold $261K over the last 12 months (1 sale).
- Last insider buy: Evert B. Schimmelpennink (CEO), $251K, 7 months ago.
Last 12 months: insiders bought $655K (5 buys) and sold $261K (1 sale). Last close $3.25 on Oct 22, 2026.
Recent LENZ insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 15, 2026 | James W McCollum (Director) | Bought (not open market) | — |
| Jun 15, 2026 | Zachary Scheiner (Director) | Bought (not open market) | — |
| Jun 15, 2026 | Jeffrey P. George (Director) | Bought (not open market) | — |
| Jun 15, 2026 | Kimberlee C Drapkin (Director) | Bought (not open market) | — |
| Jun 15, 2026 | Shelley B Thunen (Director) | Bought (not open market) | — |
| Jun 15, 2026 | Frederic Guerard (Director) | Bought (not open market) | — |
| Jun 15, 2026 | Ra Capital Management L.p. (Insider) | Bought (not open market) | — |
| Mar 27, 2026 | Evert B. Schimmelpennink (CEO) | Bought | $251K |
| Mar 27, 2026 | Daniel R. Chevallard (CFO) | Bought | $64.3K |
| Mar 27, 2026 | Jeffrey P. George (Director) | Bought | $49.9K |
| Jan 2, 2026 | Daniel R. Chevallard (CFO) | Bought (not open market) | — |
| Jan 2, 2026 | Daniel R. Chevallard (CFO) | Bought (not open market) | — |
| Jan 2, 2026 | Shawn Olsson (C-suite exec) | Bought (not open market) | — |
| Jan 2, 2026 | Evert B. Schimmelpennink (CEO) | Bought (not open market) | — |
| Jan 2, 2026 | Shawn Olsson (C-suite exec) | Bought (not open market) | — |
| Jan 2, 2026 | Marc Odrich (C-suite exec) | Bought (not open market) | — |
| Jan 2, 2026 | Marc Odrich (C-suite exec) | Bought (not open market) | — |
| Nov 17, 2025 | Shawn Olsson (C-suite exec) | Sold | $153K |
| Nov 17, 2025 | Shawn Olsson (C-suite exec) | Sold | $108K |
| Nov 17, 2025 | Shawn Olsson (C-suite exec) | Bought (not open market) | — |
| Nov 7, 2025 | James W McCollum (Director) | Bought | $239K |
| Nov 7, 2025 | Daniel R. Chevallard (CFO) | Bought | $49.6K |
| Nov 7, 2025 | Daniel R. Chevallard (CFO) | Bought | $454 |
Who's trading LENZ
- Zachary Scheiner, Director: other filings, last Jun 15, 2026
- Shelley B Thunen, Director: other filings, last Jun 15, 2026
- Jeffrey P. George, Director: bought $49.9K (1 buy), last Jun 15, 2026
- Frederic Guerard, Director: other filings, last Jun 15, 2026
- James W McCollum, Director: bought $239K (1 buy), last Jun 15, 2026
- Kimberlee C Drapkin, Director: other filings, last Jun 15, 2026
- Ra Capital Management L.p., Insider: other filings, last Jun 15, 2026
- Evert B. Schimmelpennink, CEO: bought $251K (1 buy), last Mar 27, 2026
- Daniel R. Chevallard, CFO: bought $114K (3 buys), last Mar 27, 2026
- Shawn Olsson, C-suite exec: sold $261K (2 sales), last Jan 2, 2026
- Marc Odrich, C-suite exec: other filings, last Jan 2, 2026
Get free alerts when an insider at LENZ Therapeutics, Inc files a new trade →